Devin Jackson Email

Research Scientist . Gryphon Bio

Current Roles

Employees:
6
Revenue:
$930k
About
Traumatic brain injury (TBI), multiple sclerosis (MS), post-traumatic epilepsy (PTE), Alzheimer's disease and related dementias (ADRD), chronic traumatic encephalopathy (CTE), and related indications are leading causes of death and disability. Gryphon Bio is a preclinical-stage therapeutic bioconjugate company created to harness our co-founders' discovery of novel therapeutic targets and temporal biomarkers in unexpected waves of brain molecules in the blood. Mission: To develop and market the 1st therapeutic bioconjugate to accelerate brain repair and improve cognition. Vision: To pioneer therapeutic bioconjugates to improve the lives of patients with neurological or neurodegenerative diseases.
Gryphon Bio Address
1 Mandalay Pl
San Francisco, CA
United States
Gryphon Bio Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.